Cost Evaluation of Minimally Invasive Tissue Sampling (MITS) Implementation in Low- and Middle-Income Countries.
Laura T R MorrisonElizabeth G BrownChristina R PaganelliSuraj BhattaraiRahell HailuGervais NtakirutimanaDjibril MbarushimanaNuwadatta SubediNorman GocoPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Variation in each site's use of staff roles and testing protocols suggests sites conducting MITS may adapt use of resources based on available expertise, equipment, and surveillance objectives. This study is a first step toward necessary examinations of cost-effectiveness, which may provide insight into cost optimization and economic justification for the expansion of MITS.